Skip to main content

Cabot Corporation

corporate_fare Company Profile

Cabot Corporation

CBT·NYSE·Industrial Applications And Services·CIK 0000016040

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company, founded in 1882 and incorporated in Delaware in 1960, manufactures principal products including reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants, and aerogel. Cabot and its affiliates operate manufacturing facilities and operations in the United States and over 20 other countries. The company's products are based on technical expertise and innovation in four core competencies: making and handling very fine particles; modifying the surfaces of very fine particles to alter their functionality; designing particles to impart specific properties to a formulation; and combining particles with other ingredients to deliver a formulated performance intermediate or composite. Cabot focuses on creating particles and formulations with specific composition, morphology, and surface functionalities to support customer applications. The business is organized into two reportable segments: Reinforcement Materials and Performance Chemicals.

Cabot Corporation (NYSE:CBT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for CBT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for CBT spans 8-K, 144, 10-Q.

Recent high-impact activity:

  • Cabot Guides FY2027 Adjusted EPS to $6.15-$6.75 After Q4 Adjusted EPS of $1.61
  • Cabot Posts 4Q EPS of $1.25
  • Cabot Secures Modified $50M DOE Grant to Expand Battery Materials
  • Outgoing CEO Keohane Files to Sell Another $11.5M in Cabot Shares
  • Retiring CEO Sean Keohane Files to Sell $7.94M in Shares

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$3.71B
Net Income
$331M
Diluted EPS
$6.02
Op. Cash Flow
$665M
Free Cash Flow
$391M
Gross Profit
$940M
Operating Income
$621M
Cash & Equivalents
$258M
Total Debt
$1.12B
Debt / Equity
0.72×
Net Margin
8.9%
Shares Outstanding
52.84M sh
Source: 10-K · filed 2025-11-24 · accession 0001193125-25-292412

Short Interest & Short Volume

12.54 days to cover

FINRA reported short interest of 4,923,877 shares in CBT as of the October 15, 2026 settlement, a 11.4% increase from the prior period — about 12.5 days to cover at its recent average daily volume. On November 2, 2026, 59.8% of CBT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,923,877 shares as of October 15, 2026
Change vs prior period▲ 11.4%
Days to cover12.54 at avg daily volume of 392,525
Daily short volume (FINRA facilities)59.8% of 177,841 shares on November 2, 2026
5-day average short volume61.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$74.5 -1.61% today
52-week range · as of 2026-11-02 $58.33 – $94.53
Market cap
$3.91B
Volume
617.1K (1.6× avg)
3-mo avg 392.3K
Live data · 2026-11-03 09:22 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed CBT - Latest Insights

CBT
Nov 02, 2026, 5:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $74.50
Real-time Price: $74.50 info
Change: $0 (0%) info
Market Cap: $3.909B info
CBT
Nov 02, 2026, 4:31 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $75.72
Real-time Price: $74.50 info
Change: -$1.22 (-2%) info
Market Cap: $3.909B info
CBT
Sep 17, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $78.87
Real-time Price: $74.50 info
Change: -$4.37 (-6%) info
Market Cap: $3.909B info
CBT
Aug 28, 2026, 10:21 AM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $84.43
Real-time Price: $74.50 info
Change: -$9.92 (-12%) info
Market Cap: $3.909B info
CBT
Aug 07, 2026, 3:19 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $87.38
Real-time Price: $74.50 info
Change: -$12.88 (-15%) info
Market Cap: $3.909B info
CBT
Aug 04, 2026, 2:58 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $81.20
Real-time Price: $74.50 info
Change: -$6.70 (-8%) info
Market Cap: $3.909B info
CBT
Aug 03, 2026, 4:52 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $89.58
Real-time Price: $74.50 info
Change: -$15.08 (-17%) info
Market Cap: $3.909B info
CBT
Aug 03, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.83
Real-time Price: $74.50 info
Change: -$5.33 (-7%) info
Market Cap: $3.909B info
CBT
Aug 03, 2026, 4:36 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $89.58
Real-time Price: $74.50 info
Change: -$15.08 (-17%) info
Market Cap: $3.909B info
CBT
Jul 30, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $91.43
Real-time Price: $74.50 info
Change: -$16.93 (-19%) info
Market Cap: $3.909B info
CBT
May 14, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.90
Real-time Price: $74.50 info
Change: -$8.40 (-10%) info
Market Cap: $3.909B info
CBT
May 06, 2026, 4:23 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $82.41
Real-time Price: $74.50 info
Change: -$7.91 (-10%) info
Market Cap: $3.909B info
CBT
May 05, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.66
Real-time Price: $74.50 info
Change: -$5.16 (-6%) info
Market Cap: $3.909B info
CBT
May 05, 2026, 4:30 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $78.93
Real-time Price: $74.50 info
Change: -$4.43 (-6%) info
Market Cap: $3.909B info
CBT
May 04, 2026, 7:16 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $75.85
Real-time Price: $74.50 info
Change: -$1.35 (-2%) info
Market Cap: $3.909B info
CBT
Feb 04, 2026, 1:36 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $78.93
Real-time Price: $74.50 info
Change: -$4.43 (-6%) info
Market Cap: $3.909B info
CBT
Feb 03, 2026, 4:40 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $71.20
Real-time Price: $74.50 info
Change: +$3.30 (+5%) info
Market Cap: $3.909B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets